Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for freezing of gait and attention in Parkinson's disease (FOGG-I)
2008-008210-38Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of memantine in Parkinson's disease (PD), sponsored by CHU de Lille. Primary endpoint: Step length during gait analysis. Started Mar 2009; status: completed.
02
Drugs
memantine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-008210-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008210-38.